Loading…
Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion
Microbial contamination associated with different methods of neonatal intravenous fat emulsion (IVFE) preparation and delivery was evaluated. Sterility testing was performed on IVFE dispensed via three different methods: (1) in the original container (n = 60), (2) repackaged into a syringe (n = 90),...
Saved in:
Published in: | American journal of health-system pharmacy 2010-06, Vol.67 (11), p.914-918 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c384t-edb4beaa20cb015643efdade7f7ac69b54c56e6d0131747d9a5f06e2bf7a849b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c384t-edb4beaa20cb015643efdade7f7ac69b54c56e6d0131747d9a5f06e2bf7a849b3 |
container_end_page | 918 |
container_issue | 11 |
container_start_page | 914 |
container_title | American journal of health-system pharmacy |
container_volume | 67 |
creator | Crill, Catherine M Hak, Emily B Robinson, Lawrence A Helms, Richard A |
description | Microbial contamination associated with different methods of neonatal intravenous fat emulsion (IVFE) preparation and delivery was evaluated.
Sterility testing was performed on IVFE dispensed via three different methods: (1) in the original container (n = 60), (2) repackaged into a syringe (n = 90), and (3) drawdown of the original container (n = 60). At the end of each infusion (24 hours for methods 1 and 3, 12 hours for method 2), a sample of the IVFE was withdrawn from the container using a sterile syringe in an International Organization for Standardization class 5 hood and sent to the hospital microbiology laboratory, where the samples were introduced into blood culture bottles and incubated for five days. Each sample was then subcultured on a blood agar plate with olive oil and left for an additional two days in a carbon dioxide incubator to assess for Malassezia furfur.
None of the samples from the original containers showed bacterial or fungal growth. Three of the samples from syringes had bacterial growth (two samples contained coagulase-negative staphylococcus and one contained both Klebsiella oxytoca and Citrobacter freundii), yielding a contamination rate of 3.3%. The number of contaminated samples did not significantly differ among the three preparation methods (p = 0.13).
Repackaging IVFE into sterile syringes resulted in bacterial contamination and should be avoided in clinical practice. IVFE samples obtained using the drawdown procedure under sterile conditions for infusion over 24 hours revealed no microbial contamination. |
doi_str_mv | 10.2146/ajhp090199 |
format | article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_733548228</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A231714685</galeid><sourcerecordid>A231714685</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-edb4beaa20cb015643efdade7f7ac69b54c56e6d0131747d9a5f06e2bf7a849b3</originalsourceid><addsrcrecordid>eNptkV1r1zAUxoM43Jze-AGkICgMOpM0fbscY3ODgTd6HU6bkzWjbWqSrnjrJ9_506kIkosccn7Pw5NzGHsn-LkUqvoMD8PCWy7a9gU7EWVR5rLl_CXVvG5zyRt5zF7H-MC5kA2vXrFjyVWjpChP2K-rRxhXSM7PmbfZ5PrgOwdj1vs5weTmvQUx-t5BQpNtLg2ZcdZiwDllS8AFwk5NmAZvYmZ9yGb0pCUjN6cAjzj7lRqQMpzWMR5oN9v1ULxhRxbGiG-f71P2_frq2-VNfvf1y-3lxV3eF41KOZpOdQgged9xUVaqQGvAYG1r6Ku2K1VfVlgZLgpRq9q0UFpeoeyo36i2K07Zp913Cf7HijHpycUexxEo6xp1XRSlaqRsiPywk_cwoqacnr7QH2h9Icmdht6URJ3_h6JjkMboZ7SO3v8RnO0CmnGMAa1egpsg_NSC68Mm9d9NEvz-Oe3aTWj-oL9XR8DHHRjc_bC5gDpOMI6ES71tW1VrIXQrVPEETqyqAg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733548228</pqid></control><display><type>article</type><title>Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion</title><source>Oxford Journals Online</source><creator>Crill, Catherine M ; Hak, Emily B ; Robinson, Lawrence A ; Helms, Richard A</creator><creatorcontrib>Crill, Catherine M ; Hak, Emily B ; Robinson, Lawrence A ; Helms, Richard A</creatorcontrib><description>Microbial contamination associated with different methods of neonatal intravenous fat emulsion (IVFE) preparation and delivery was evaluated.
Sterility testing was performed on IVFE dispensed via three different methods: (1) in the original container (n = 60), (2) repackaged into a syringe (n = 90), and (3) drawdown of the original container (n = 60). At the end of each infusion (24 hours for methods 1 and 3, 12 hours for method 2), a sample of the IVFE was withdrawn from the container using a sterile syringe in an International Organization for Standardization class 5 hood and sent to the hospital microbiology laboratory, where the samples were introduced into blood culture bottles and incubated for five days. Each sample was then subcultured on a blood agar plate with olive oil and left for an additional two days in a carbon dioxide incubator to assess for Malassezia furfur.
None of the samples from the original containers showed bacterial or fungal growth. Three of the samples from syringes had bacterial growth (two samples contained coagulase-negative staphylococcus and one contained both Klebsiella oxytoca and Citrobacter freundii), yielding a contamination rate of 3.3%. The number of contaminated samples did not significantly differ among the three preparation methods (p = 0.13).
Repackaging IVFE into sterile syringes resulted in bacterial contamination and should be avoided in clinical practice. IVFE samples obtained using the drawdown procedure under sterile conditions for infusion over 24 hours revealed no microbial contamination.</description><identifier>ISSN: 1079-2082</identifier><identifier>EISSN: 1535-2900</identifier><identifier>DOI: 10.2146/ajhp090199</identifier><identifier>PMID: 20484215</identifier><language>eng</language><publisher>England: American Society of Health-System Pharmacists</publisher><subject>Bacteria - isolation & purification ; Contamination ; Drug Compounding - methods ; Drug Compounding - standards ; Drug Contamination ; Drug Packaging ; Drug Storage ; Fat Emulsions, Intravenous - standards ; Humans ; Hypodermic needles ; Hypodermic syringes ; Infant, Newborn ; Infusions, Intravenous ; Intravenous therapy ; Microbial contamination ; Pharmacy Service, Hospital - methods ; Prevention ; Safety and security measures ; Syringes ; Syringes - microbiology ; Time Factors</subject><ispartof>American journal of health-system pharmacy, 2010-06, Vol.67 (11), p.914-918</ispartof><rights>COPYRIGHT 2010 Oxford University Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-edb4beaa20cb015643efdade7f7ac69b54c56e6d0131747d9a5f06e2bf7a849b3</citedby><cites>FETCH-LOGICAL-c384t-edb4beaa20cb015643efdade7f7ac69b54c56e6d0131747d9a5f06e2bf7a849b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20484215$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Crill, Catherine M</creatorcontrib><creatorcontrib>Hak, Emily B</creatorcontrib><creatorcontrib>Robinson, Lawrence A</creatorcontrib><creatorcontrib>Helms, Richard A</creatorcontrib><title>Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion</title><title>American journal of health-system pharmacy</title><addtitle>Am J Health Syst Pharm</addtitle><description>Microbial contamination associated with different methods of neonatal intravenous fat emulsion (IVFE) preparation and delivery was evaluated.
Sterility testing was performed on IVFE dispensed via three different methods: (1) in the original container (n = 60), (2) repackaged into a syringe (n = 90), and (3) drawdown of the original container (n = 60). At the end of each infusion (24 hours for methods 1 and 3, 12 hours for method 2), a sample of the IVFE was withdrawn from the container using a sterile syringe in an International Organization for Standardization class 5 hood and sent to the hospital microbiology laboratory, where the samples were introduced into blood culture bottles and incubated for five days. Each sample was then subcultured on a blood agar plate with olive oil and left for an additional two days in a carbon dioxide incubator to assess for Malassezia furfur.
None of the samples from the original containers showed bacterial or fungal growth. Three of the samples from syringes had bacterial growth (two samples contained coagulase-negative staphylococcus and one contained both Klebsiella oxytoca and Citrobacter freundii), yielding a contamination rate of 3.3%. The number of contaminated samples did not significantly differ among the three preparation methods (p = 0.13).
Repackaging IVFE into sterile syringes resulted in bacterial contamination and should be avoided in clinical practice. IVFE samples obtained using the drawdown procedure under sterile conditions for infusion over 24 hours revealed no microbial contamination.</description><subject>Bacteria - isolation & purification</subject><subject>Contamination</subject><subject>Drug Compounding - methods</subject><subject>Drug Compounding - standards</subject><subject>Drug Contamination</subject><subject>Drug Packaging</subject><subject>Drug Storage</subject><subject>Fat Emulsions, Intravenous - standards</subject><subject>Humans</subject><subject>Hypodermic needles</subject><subject>Hypodermic syringes</subject><subject>Infant, Newborn</subject><subject>Infusions, Intravenous</subject><subject>Intravenous therapy</subject><subject>Microbial contamination</subject><subject>Pharmacy Service, Hospital - methods</subject><subject>Prevention</subject><subject>Safety and security measures</subject><subject>Syringes</subject><subject>Syringes - microbiology</subject><subject>Time Factors</subject><issn>1079-2082</issn><issn>1535-2900</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNptkV1r1zAUxoM43Jze-AGkICgMOpM0fbscY3ODgTd6HU6bkzWjbWqSrnjrJ9_506kIkosccn7Pw5NzGHsn-LkUqvoMD8PCWy7a9gU7EWVR5rLl_CXVvG5zyRt5zF7H-MC5kA2vXrFjyVWjpChP2K-rRxhXSM7PmbfZ5PrgOwdj1vs5weTmvQUx-t5BQpNtLg2ZcdZiwDllS8AFwk5NmAZvYmZ9yGb0pCUjN6cAjzj7lRqQMpzWMR5oN9v1ULxhRxbGiG-f71P2_frq2-VNfvf1y-3lxV3eF41KOZpOdQgged9xUVaqQGvAYG1r6Ku2K1VfVlgZLgpRq9q0UFpeoeyo36i2K07Zp913Cf7HijHpycUexxEo6xp1XRSlaqRsiPywk_cwoqacnr7QH2h9Icmdht6URJ3_h6JjkMboZ7SO3v8RnO0CmnGMAa1egpsg_NSC68Mm9d9NEvz-Oe3aTWj-oL9XR8DHHRjc_bC5gDpOMI6ES71tW1VrIXQrVPEETqyqAg</recordid><startdate>20100601</startdate><enddate>20100601</enddate><creator>Crill, Catherine M</creator><creator>Hak, Emily B</creator><creator>Robinson, Lawrence A</creator><creator>Helms, Richard A</creator><general>American Society of Health-System Pharmacists</general><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100601</creationdate><title>Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion</title><author>Crill, Catherine M ; Hak, Emily B ; Robinson, Lawrence A ; Helms, Richard A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-edb4beaa20cb015643efdade7f7ac69b54c56e6d0131747d9a5f06e2bf7a849b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Bacteria - isolation & purification</topic><topic>Contamination</topic><topic>Drug Compounding - methods</topic><topic>Drug Compounding - standards</topic><topic>Drug Contamination</topic><topic>Drug Packaging</topic><topic>Drug Storage</topic><topic>Fat Emulsions, Intravenous - standards</topic><topic>Humans</topic><topic>Hypodermic needles</topic><topic>Hypodermic syringes</topic><topic>Infant, Newborn</topic><topic>Infusions, Intravenous</topic><topic>Intravenous therapy</topic><topic>Microbial contamination</topic><topic>Pharmacy Service, Hospital - methods</topic><topic>Prevention</topic><topic>Safety and security measures</topic><topic>Syringes</topic><topic>Syringes - microbiology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Crill, Catherine M</creatorcontrib><creatorcontrib>Hak, Emily B</creatorcontrib><creatorcontrib>Robinson, Lawrence A</creatorcontrib><creatorcontrib>Helms, Richard A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of health-system pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Crill, Catherine M</au><au>Hak, Emily B</au><au>Robinson, Lawrence A</au><au>Helms, Richard A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion</atitle><jtitle>American journal of health-system pharmacy</jtitle><addtitle>Am J Health Syst Pharm</addtitle><date>2010-06-01</date><risdate>2010</risdate><volume>67</volume><issue>11</issue><spage>914</spage><epage>918</epage><pages>914-918</pages><issn>1079-2082</issn><eissn>1535-2900</eissn><abstract>Microbial contamination associated with different methods of neonatal intravenous fat emulsion (IVFE) preparation and delivery was evaluated.
Sterility testing was performed on IVFE dispensed via three different methods: (1) in the original container (n = 60), (2) repackaged into a syringe (n = 90), and (3) drawdown of the original container (n = 60). At the end of each infusion (24 hours for methods 1 and 3, 12 hours for method 2), a sample of the IVFE was withdrawn from the container using a sterile syringe in an International Organization for Standardization class 5 hood and sent to the hospital microbiology laboratory, where the samples were introduced into blood culture bottles and incubated for five days. Each sample was then subcultured on a blood agar plate with olive oil and left for an additional two days in a carbon dioxide incubator to assess for Malassezia furfur.
None of the samples from the original containers showed bacterial or fungal growth. Three of the samples from syringes had bacterial growth (two samples contained coagulase-negative staphylococcus and one contained both Klebsiella oxytoca and Citrobacter freundii), yielding a contamination rate of 3.3%. The number of contaminated samples did not significantly differ among the three preparation methods (p = 0.13).
Repackaging IVFE into sterile syringes resulted in bacterial contamination and should be avoided in clinical practice. IVFE samples obtained using the drawdown procedure under sterile conditions for infusion over 24 hours revealed no microbial contamination.</abstract><cop>England</cop><pub>American Society of Health-System Pharmacists</pub><pmid>20484215</pmid><doi>10.2146/ajhp090199</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1079-2082 |
ispartof | American journal of health-system pharmacy, 2010-06, Vol.67 (11), p.914-918 |
issn | 1079-2082 1535-2900 |
language | eng |
recordid | cdi_proquest_miscellaneous_733548228 |
source | Oxford Journals Online |
subjects | Bacteria - isolation & purification Contamination Drug Compounding - methods Drug Compounding - standards Drug Contamination Drug Packaging Drug Storage Fat Emulsions, Intravenous - standards Humans Hypodermic needles Hypodermic syringes Infant, Newborn Infusions, Intravenous Intravenous therapy Microbial contamination Pharmacy Service, Hospital - methods Prevention Safety and security measures Syringes Syringes - microbiology Time Factors |
title | Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T23%3A05%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20microbial%20contamination%20associated%20with%20different%20preparation%20methods%20for%20neonatal%20intravenous%20fat%20emulsion%20infusion&rft.jtitle=American%20journal%20of%20health-system%20pharmacy&rft.au=Crill,%20Catherine%20M&rft.date=2010-06-01&rft.volume=67&rft.issue=11&rft.spage=914&rft.epage=918&rft.pages=914-918&rft.issn=1079-2082&rft.eissn=1535-2900&rft_id=info:doi/10.2146/ajhp090199&rft_dat=%3Cgale_proqu%3EA231714685%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c384t-edb4beaa20cb015643efdade7f7ac69b54c56e6d0131747d9a5f06e2bf7a849b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733548228&rft_id=info:pmid/20484215&rft_galeid=A231714685&rfr_iscdi=true |